Glial activation: A driving force for pathological pain

Trends in Neurosciences

Volumn 24, Issue 8, 2001, Pages 450-455

  Watkins, Linda R ^a   Milligan, Erin D ^a   Maier, Steven F ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; ARACHIDONIC ACID DERIVATIVE; CYTOKINE; EXCITATORY AMINO ACID; FRACTALKINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR;

ASTROCYTE; CELL ACTIVATION; CYTOKINE RELEASE; GLIA CELL; HUMAN; HYPERALGESIA; IMMUNOCOMPETENT CELL; MICROGLIA; NERVE INJURY; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; SENSORY STIMULATION; SPINAL CORD INFECTION;

ANIMALS; HUMANS; NEUROGLIA; PAIN; SPINAL CORD;

EID: 0035426434     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01854-3     Document Type: Review

References (68)

1. Astroglial modulation of neurotransmitter/peptide release from the neurohypophysis: Present status
2. Glia-neuron intercommunications and synaptic plasticity
3. The pain of being sick: Implications of immune-to-brain communication for understanding pain
4. Neuronal plasticity: Increasing the gain in pain
5. Severe abdominal pain in patients with AIDS: Frequency, clinical aspects, causes, and outcome
6. Abdominal pain in HIV infection
7. Neuropathic pain
8. Does the right side know what the left is doing?
9. Glia: Listening and talking to the synapse
10. 2+ elevation in response to various neuroactive substances
11. Regulation of the phosphorylation of glial fibrillary acidic protein (GFAP) by glutamate and calcium ions in slices of immature rat spinal cord: Comparison with immature hippocampus
12. Functional characterization of substance P receptors on cultured human spinal cord astrocytes: Synergism of substance P with cytokines in inducing interleukin-6 and prostaglandin E2 production
13. Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system
14. Microglial-neuronal interactions in synaptic damage and recovery
15. Plasticity of astrocytes
16. Immunologically induced electrophysiological dysfunction: Implications for inflammatory diseases
17. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury
18. GFAP expression in lumbar spinal cord of naive and neuropathic rats treated with MK-801
19. Microglial reactions after subcutaneous formalin injection into the rat hind paw
20. Acute peripheral inflammation induces moderate glial activation and spinal IL-1 beta expression that correlates with pain behavior in the rat
21. Proinflammatory cytokines and glial cells: Their role in neuropathic pain
22. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain
23. Spinal glial activation and cytokine expression after lumbar root injury in the rat
24. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior
25. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats
26. Intrathecal HIV-1 envelope glycoprotein gp120 enhanced pain states mediated by spinal cord proinflammatory cytokines
27. The involvement of glial cells in the development of morphine tolerance
28. Substance P receptors on O-2A progenitor cells and type-2 astrocytes in vitro
29. 2+ signaling in cultured rat astrocytes
30. Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia
31. The effect of nitric oxide on cytokine-induced release of PGE2 by human cultured astroglial cells
32. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes
33. Characterization of fractalkine in rat brain cells: Migratory and activation signals for CX3CR-1-expressing microglia
34. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage
35. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat
36. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat
37. Propentofylline, a glial modulating agent, exhibits anti-allodynic properties in a rat model of neuropathic pain
38. Central administration of methotrexate reduces mechanical allodynia in an animal model of low pack pain associated with radiculopathy
39. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the Human Immunodeficiency Virus-1 (HIV-1) envelope glycoprotein, gp120
40. Spinal fractalkine induces allodynia and hyperalgesia
41. Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices
42. Central neuron-glial and glial-glial interactions following axon injury
43. Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide
44. Substance P stimulates IL-1 production by astrocytes via intracellular calcium
45. Substance P enhances the secretion of tumor necrosis factor-alpha from neuroglial cells stimulated with lipopolysaccharide
46. Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and nuclear factor-IL-6
47. Gp-41-mediated astrocyte inducible nitric oxide synthase mRNA expression: Involvement of interleukin-1beta production by microglia
48. Astrocytes modulate nitric oxide production by microglial cells through secretion of serine and glycine
49. Inflammatory' cytokine: Neuromodulators in normal brain?
50. Brain-derived TNFα mediates neuropathic pain
51. Receptor mediated endocytosis and intracellular fate of interleukin 1
52. Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice
53. Brain-derived TNFalpha: Involvement in neuroplastic changes implicated in the conscious perception of persistent pain
54. Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model
55. IL1ra and sTNFr reduce mechanical allodynia and spinal cytokine expression in a model of neuropathic pain
56. Cytokine involvement in dynorphin-induced allodynia
57. Induction of nociceptive responses by intrathecal injection of interleukin-1 in mice
58. Antibody and IgG attenuates mechanical allodynia in a mononeuropathy model in the rat: Potential role of immune modulation in neuropathic pain
59. Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice
60. Dynamic regulation of the proinflammatory cytokine, interleukin-1 beta: Molecular biology for non-molecular biologists
61. Glial proinflammatory cytokines mediate exaggerated pain states: Implications for clinical pain
62. Interleukin (IL)-6 mediated hyperalgesia/allodynia and increased spinal IL-6 in a rat mononeuropathy model
63. Cytokine expression in the brain during the acquired immunodeficiency syndrome
64. Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: A phase I/II study
65. The case of the missing brain: Arguments for a role of brain-to-spinal cord pathways in pain facilitation
66. A new model of sciatic inflammatory neuritis (SIN): Induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats
67. Spinal cord glia: New players in pain